AXIM Launches New Eye Care Website; Establishes Platform for Commercialization
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
Staff
Oncternal Therapeutics to Participate in the Jefferies Healthcare Conference 2022
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Scilex Holding Company, a Sorrento Company, announces continued growth in ZTlido® in managed health care plans
Earlier this year, a national pharmacy benefit manager (PBM) moved a large percentage of its patients from not covered to...
Renibus Therapeutics Expands Leadership Team, Announces Appointments of New Chief Financial Officer and Chief Medical Officer
Jamie Donadio Jamie Donadio, CFO, Renibus Therapeutics Dr. Bhupinder Singh Dr. Bhupinder Singh, CMO, Renibus TherapeuticsJamie Donadio appointed Chief Financial...
Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex
Transaction expected to significantly advance commercial readiness of NanoSynex’s innovative diagnostics technology platform focused on the $30+ Billion global infectious...
Gradalis Appoints Steven Engle as Chief Executive Officer
DALLAS, June 02, 2022 (GLOBE NEWSWIRE) -- Gradalis, a late-stage stage biotechnology company developing immunotherapies for multiple cancer indications, announced...
Hillstream BioPharma Provides Corporate Update
Hillstream BioPharma CEO Issues June 2022 Corporate Update Hillstream BioPharma CEO Issues June 2022 Corporate UpdateRecent milestones include FDA Orphan...
Cybrexa Therapeutics to Present at Upcoming Investor Conferences in June
NEW HAVEN, Conn., June 02, 2022 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class...
Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
SELLAS Life Sciences to Present at the JMP Securities Life Sciences Conference on June 15th
NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused...
Assure Holdings Executes Strategy to Make Business Leaner and More Profitable
DENVER, June 02, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Vaxart Reports Positive Preliminary Data from the Phase 1b Trial of its Oral Norovirus Vaccine Candidates in Elderly Adults
Results support safety and immunogenicity of the vaccine candidate in the highly vulnerable elderly population Preliminary boost study data also...
Solid Biosciences Reports Inducement Grant to New Senior Vice President, Quality
CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:...
New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022
New data on Helsinn’s oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022 Lugano, Switzerland, June...
Plantable Health Welcomes James (Jim) Wachtel as Chief Growth Officer
Growth Strategist Veteran Joins Plantable To Boost Business GrowthNew York, New York--(Newsfile Corp. - June 2, 2022) - Plantable® Health...
Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder
Study Initiated Following Recent Successful Pilot Study and Patent FilingToronto, Ontario--(Newsfile Corp. - June 2, 2022) - Awakn Life Sciences...
Therma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
Toronto, Ontario--(Newsfile Corp. - June 2, 2022) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the...
Glaukos Announces Participation in the William Blair Growth Stock Conference
SAN CLEMENTE, Calfi.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Study Data Show Premia Spine’s TOPS™ Spinal Arthroplasty System Is Cost-effective Compared With TLIF, Becomes Dominant Strategy Over Time
First-of-a-kind TOPS System designed to offer treatment alternative for patients with spinal stenosis and spondylolisthesis NORWALK, Conn.--(BUSINESS WIRE)--Premia Spine, a...